← Eichor
Study identifier: NCT06000943 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ischemic And Bleeding Risk Assessment After TAVR

Condition: Aortic Valve Stenosis · Transcatheter Aortic Valve Replacement  ·  Sponsor: Niguarda Hospital

PhaseN/A
Planned participants2500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Transcatheter aortic valve replacement (TAVR) represents an effective treatment to improve symptoms and prognosis in patients with symptomatic severe aortic stenosis (AS) (1-2). Giving an established uniform approach towards anticoagulation and antithrombotic therapy after TAVR in the post POPULAR-TAVI era, recent data coming from the analysis of different trials, highlight the relevance of the patient's background on the occurrence of ischemic and bleeding events. Despite this a targeted antithrombotic strategy remains unexplored and all patients undergoing TAVR without other indication to DAPT or OAC, were currently treated according with the concept of "less is more" (only SAPT or only OAC) regardless the risk level (5-6). The keys points of the project will be 1) the assessment of ischemic and bleeding risk after TAVR stratified according with antithrombotic therapy and surgical risk; 2) the evaluation of the impact of prostheses type and the complete blood count variables (hemoglobine and platelets) on the daily average ischemic and bleeding risk and 3) the evaluation of the dynamic therapeutic changes after TAVR during the follow up.

This description comes directly from the study's public registry record.

Talk to the study team

Giuseppe Esposito, MD  ·  +393278393131  ·  giuseppe.esposito@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (12)

OLV HospitalAalst, BelgiumRecruiting
Complejo Asistencial Dr. Sótero del RíoSantiago, ChileRecruiting
Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske VinohradyPrague, CzechiaRecruiting
ASST GOM NiguardaMilan, Italia, ItalyRecruiting
Humanitas Research HospitalRozzano, Milano, ItalyRecruiting
IRCCS Policlinico San DonatoSan Donato Milanese, Milano, ItalyRecruiting
IRCCS Ospedale Policlinico San MartinoGenova, ItalyRecruiting
Ospedale Galeazzi Sant'AmbrogioMilan, ItalyRecruiting
San Carlo HospitalPotenza, ItalyRecruiting
Azienda Ospedaliera Sant'AndreaRoma, ItalyRecruiting
A.O.U. Città della Salute e della Scienza di TorinoTorino, ItalyRecruiting
Puerto Real University Hospital, Puerto RealCadiz, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06000943